Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2007 by Taichung Veterans General Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Tri-Service General Hospital
Information provided by:
Taichung Veterans General Hospital
ClinicalTrials.gov Identifier:
NCT00417950
First received: January 1, 2007
Last updated: January 3, 2007
Last verified: January 2007

January 1, 2007
January 3, 2007
January 2007
Not Provided
Postprandial hyperglycemia
Same as current
Complete list of historical versions of study NCT00417950 on ClinicalTrials.gov Archive Site
  • Postprandial inflammatory responses
  • Postprandial oxidative stress
Same as current
Not Provided
Not Provided
 
Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 Diabetes
Not Provided

To understand if acarbose, an alpha-glucosidase inhibitor usually for treating diabetes, will further lower post meal glucose and inflammatory state when taking together with moderate amount of alcohol during meal tolerance test in subjects with impaired glucose tolerance or mild diabetes.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Diabetes Mellitus
  • Impaired Glucose Tolerance
Drug: Acarbose
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
30
Not Provided
Not Provided

Inclusion Criteria:

  • Subjects with mild diabetes without prior medications or impaired glucose tolerance

Exclusion Criteria:

  • Pregnancy
  • Recent major cardiac, renal and hepatic disease
  • Intolerance to alcohol
  • Allergy to acarbose treatment
Both
25 Years to 75 Years
No
Contact: I Te Lee, MD, MS 886-4-23592525 ext 3065 itlee@vghtc.gov.tw
Taiwan
 
NCT00417950
950801/C06138
Not Provided
Not Provided
Taichung Veterans General Hospital
Tri-Service General Hospital
Principal Investigator: Wayne H Sheu, MD, PhD Taichung Veterans General Hospital
Taichung Veterans General Hospital
January 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP